Skip to main content

Table 3 Prevalence of relevant and frequent resistance-associated mutations

From: Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020

NRTI

 

NNRTI

 

PI

 

INI

 

Mutation

N (%)a

Mutation

N (%)a

Mutation

N (%)a

Mutation

N (%)b

M41L

51 (1.1)

A98G

11 (0.2)

V11I

58 (1.3)

T66I

2 (< 0.1)

K65R

5 (0.1)

K101EP

26 (0.6)

D30N

2 (< 0.1)

E92GQ

1 (< 0.1)

D67EGN

18 (0.4)

K103NS

133 (2.9)

M46IL

42 (0.9)

E138K

4 (< 0.1)

T69D

7 (0.2)

V108I

26 (0.6)

I50LV

0 (0.0)

G140AS

1 (< 0.1)

K70E

7 (0.2)

E138A

166 (3.6)

F53LY

11 (0.2)

Y143CHR

1 (< 0.1)

V75AMST

3 (< 0.1)

Y181CIV

21 (0.5)

Q58E

37 (0.8)

S147G

1 (< 0.1)

Y115F

2 (< 0.1)

Y188CHL

10 (0.2)

T74S

87 (1.9)

Q148HR

0 (0.0)

M184V

27 (0.6)

G190AES

33 (0.7)

V82ACFLTMS

23 (0.5)

N155HS

0 (0.0)

T215CDEFISVY

97 (2.1)

H221Y

8 (0.2)

I85V

4 (< 0.1)

S230R

0 (0.0)

K219ENQR

24 (0.5)

P225H

9 (0.2)

L90M

21 (0.5)

R263K

1 (< 0.1)

  1. aNRTI, NNRTI and PI are based on 4559 analyzed cases.
  2. bINI is based on 3097 analyzed cases.